Drug information provided by: Merative, Micromedex®
Niraparib is used as first-line maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is also used as maintenance treatment in patients with recurrent (cancer that comes back) ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) abnormal BRCA gene. Your doctor will test for the presence of this gene (deleterious or suspected deleterious germline BRCA gene). This medicine is used in patients who have had received platinum-based cancer medicines.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.